Graphene Nanosheet Biosensors for Early Cancer Biomarker Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current cancer diagnosis methods often result in late detection due to the lack of early physical symptoms, and there is a need for sensitive and selective biosensors to detect cancer biomarkers like PDGF-BB, which are not efficiently addressed by existing technologies.
Innovation Solution
Development of novel, label-free biosensors using electrochemical bipolar exfoliation to deposit graphene nanosheets on electrodes, combined with immobilized aptamers, enabling highly sensitive and selective detection of PDGF-BB with a low limit of detection and stable performance.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If conventional cancer diagnosis methods are used, then diagnosis can be performed with existing technology, but detection is delayed until cancer has significantly progressed
Solution Approach 1:
The patent changes the detection parameter by using electrochemical bipolar exfoliation to create graphene nanosheets with specific electrochemical properties, enabling detection at much lower concentration thresholds. This allows detection of PDGF-BB at early cancer stages when concentrations are low, resolving the contradiction between detection sensitivity and diagnosis timing.
Solution Approach 2:
The patent creates a composite sensing system combining graphene nanosheets with aptamers (DNA molecules). This composite structure enhances detection sensitivity through the unique electrochemical properties of graphene combined with the high specificity of aptamers for PDGF-BB binding, enabling early cancer detection before significant progression occurs.
2Measurement precision
If existing biosensor technologies are used, then biomarker detection can be performed, but sensitivity and selectivity are insufficient for early cancer detection
Solution Approach 1:
The patent applies local quality by creating regions of high graphene nanosheet density on the electrode surface through bipolar exfoliation. This localized enhancement of electrochemical activity at specific sites improves both sensitivity and reliability of PDGF-BB detection, as the bipolar regions provide concentrated sensing zones with enhanced electron transfer capabilities.
Solution Approach 2:
The patent uses aptamers as intermediary molecules that specifically bind to PDGF-BB biomarkers. These DNA-based intermediaries provide high selectivity by recognizing and binding only to the target biomarker, while the graphene nanosheets serve as an intermediary platform that enhances the electrochemical signal, together improving both sensitivity and detection accuracy.
3Measurement precision
If complex biosensor fabrication processes are used, then high performance can be achieved, but manufacturing complexity and cost increase
Solution Approach 1:
The patent merges multiple functions into a single fabrication step by combining exfoliation, reduction, and deposition of graphene nanosheets through electrochemical bipolar exfoliation. This consolidation of processes that would traditionally require separate steps simplifies manufacturing while maintaining high sensing performance, directly addressing the contradiction between performance and fabrication complexity.
Solution Approach 2:
The bipolar exfoliation process is self-organizing, where the electric field automatically creates regions of graphene exfoliation and deposition without requiring external masking or complex patterning steps. This self-service characteristic of the electrochemical process simplifies fabrication by eliminating the need for additional manufacturing steps, reducing both complexity and cost while achieving high-performance sensors.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The biosensors provide a highly sensitive, selective, and stable means for detecting PDGF-BB, enabling early cancer diagnosis and monitoring, with a low limit of detection below 1 picomolar and maintaining stability over several days, suitable for point-of-care applications.
Implementation Method 1
Electrochemical bipolar exfoliation can be used to exfoliate, reduce, and deposit (e.g., in a single step) graphene nanosheets on desired substrates (e.g., an electrode such as a gold electrode)
Implementation Method 2
Electrochemical bipolar exfoliation can be used to exfoliate, reduce, and deposit (e.g., in a single step) graphene nanosheets
Implementation Method 3
Affinity aptamers can be immobilized on the graphene nanosheets disposed on the substrate. The biosensors can have highly sensitive, selective, and stable sensing performance
Data Source
AI summary
Biosensors capable of detecting certain biomarkers (e.g., platelet-derived growth factor-BB (PDGF-BB)), as well as methods of fabricating the same and methods of using the same, are provided. The biosensors can be disposable and/or label-free. Electrochemical bipolar exfoliation can be used to exfoliate, reduce, and deposit (in a single step) graphene nanosheets on a desired substrate (e.g., an electrode). Affinity aptamers can be immobilized on the graphene nanosheets disposed on the substrate.